QID 239670

Date Published: 2021-10-20

QID 239670: Red Hat Update for .NET 5.0 on RHEL 7 (RHSA-2021:3818)

.NET is a managed-software framework. It implements a subset of the .NET framework APIs and several new APIs, and it includes a CLR implementation.New versions of .NET that address a security vulnerability are now available. The updated versions are .NET SDK 5.0.208 and .NET Runtime 5.0.11.

Security Fix(es): dotnet: System.DirectoryServices.Protocols.LdapConnection sends credentials in plaintext if TLS handshake fails (CVE-2021-41355)

Affected Products:

dotNET on RHEL (for RHEL Server) 1 x86_64
dotNET on RHEL (for RHEL Workstation) 1 x86_64
dotNET on RHEL (for RHEL Compute Node) 1 x86_64

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

On successful exploitation, it could allow an attacker to execute code.

  • CVSS V3 rated as Medium - 5.7 severity.
  • CVSS V2 rated as Low - 2.9 severity.
    • Solution
    Upgrade to the latest packages which contain a patch. Refer to Applying Package Updates to RHEL system for details.

    Refer to Red Hat security advisory RHSA-2021:3818 to address this issue and obtain more information.

    Vendor References

    CVEs related to QID 239670

    CVE-2021-41355 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2021:3818 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2021:3818?language=en
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].